Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020

View ORCID ProfileAzlann Arnett, David A. Siegel, Shifan Dai, Trevor D. Thompson, Jennifer Foster, Erika J. di Pierro, Behnoosh Momin, Philip J. Lupo, View ORCID ProfileAndras Heczey
doi: https://doi.org/10.1101/2024.03.25.24304564
Azlann Arnett
aCancer and Hematology Centers, Texas Children’s Hospital, Houston, Texas
eDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Azlann Arnett
David A. Siegel
bDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shifan Dai
cCyberdata Technologies, Inc., Herndon, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trevor D. Thompson
bDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Foster
aCancer and Hematology Centers, Texas Children’s Hospital, Houston, Texas
eDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika J. di Pierro
aCancer and Hematology Centers, Texas Children’s Hospital, Houston, Texas
eDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Behnoosh Momin
bDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip J. Lupo
aCancer and Hematology Centers, Texas Children’s Hospital, Houston, Texas
dCenter for Epidemiology and Population Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
eDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andras Heczey
aCancer and Hematology Centers, Texas Children’s Hospital, Houston, Texas
eDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andras Heczey
  • For correspondence: heczey{at}bcm.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance Hepatocellular carcinoma accounts for approximately 80% of liver neoplasms. Globally, hepatocellular carcinoma ranks as the third most lethal cancer, with the number of deaths expected to further increase by 2040. In adults, disparities in incidence and survival are well described while pediatric epidemiology is not well characterized.

Objective To describe incidence and survival for pediatric (ages 0-19 years) hepatocellular carcinoma cases and compare these measures to adults (ages ≥20 years) diagnosed with hepatocellular carcinoma. We evaluated demographic factors and clinical characteristics that influence incidence and outcomes.

Design Population-based cohort study.

Setting Incidence data from the US Cancer Statistics database from 2003 to 2020 and 5-year relative survival from the National Program of Cancer Registries from 2001 to 2019, covering 97% and 83% of the US population, respectively.

Participants 355,349 US Cancer Statistics and 257,406 the National Program of Cancer Registries patients were identified using ICD-O-3 C22.0 and 8170-5 codes.

Main Outcomes and Measures Incidence annual percent change (APC) and average APC (AAPC) using joinpoint regression. Five-year relative survival. All-cause survival estimated using multivariate Cox modeling. Corresponding 95% confidence intervals (CI) were calculated.

Results Incidence rate per 100,000 persons was 0.056 (95%CI:0.052-0.060) for pediatric cases and 7.793 (7.767-7.819) for adults. Incidence was stable in the pediatric population (0.3 AAPC, −1.1-1.7). In contrast, after periods of increase, incidence declined in adults after 2015 (−1.5 APC). Relative survival increased over time for both pediatric and adult ages and was higher for children and adolescents (46.4%, 95%CI:42.4-50.3) than adults (20.7%, 95%CI:20.5-20.9) overall and when stratified by stage. Regression modeling showed that non-Hispanic Black race and ethnicity was associated with higher risk of death in children and adolescents (1.48, 95%CI:1.07-2.05) and adults (1.11, 95%CI:1.09-1.12) compared to non-Hispanic white race and ethnicity.

Conclusions and Relevance Between 2003 and 2020 in the United States, pediatric incidence was stable while incidence in adults began to decline after 2015. Survival was higher across all stages for children and adolescents compared to adults. Non-Hispanic Black race and ethnicity showed a higher risk of death for both age groups. Further studies could explore the factors that influence these outcome disparities.

Question How does incidence and survival compare between pediatric and adult hepatocellular carcinoma (HCC)?

Findings In contrast to adults, pediatric incidence rates of HCC were stable, and no demographic risk factors for incidence were identified. Pediatric HCC survival was higher than adults. Non-Hispanic Black race and ethnicity, small metropolitan county, and non-fibrolamellar histology, were risk factors in both pediatric and adult groups.

Meaning Non-Hispanic Black patients and those living in smaller metropolitan and non-metropolitan areas irrespective of age might benefit from further research in outcome disparities, provider education, and prospective studies to maximize outcomes through effective risk-adapted management strategies.

Competing Interest Statement

Andras Heczey has consultancy / scientific advisory roles with Waypoint Bio and Cargo Therapeutics. All the other authors declare that they have no competing financial interests.

Funding Statement

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM136554 and internal funding from the Center for Advanced Innate Cell Therapy of Texas Childrens Cancer Center Houston United States.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

  • Author names adjusted. Disclosure of advisory role added.

Data Availability

The data that support the findings of this study are available on request by contacting uscsdata{at}cdc.gov. The data are not publicly available due to privacy and legal restrictions.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted April 05, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020
Azlann Arnett, David A. Siegel, Shifan Dai, Trevor D. Thompson, Jennifer Foster, Erika J. di Pierro, Behnoosh Momin, Philip J. Lupo, Andras Heczey
medRxiv 2024.03.25.24304564; doi: https://doi.org/10.1101/2024.03.25.24304564
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020
Azlann Arnett, David A. Siegel, Shifan Dai, Trevor D. Thompson, Jennifer Foster, Erika J. di Pierro, Behnoosh Momin, Philip J. Lupo, Andras Heczey
medRxiv 2024.03.25.24304564; doi: https://doi.org/10.1101/2024.03.25.24304564

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3290)
  • Dentistry and Oral Medicine (364)
  • Dermatology (278)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1170)
  • Epidemiology (13371)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (782)
  • Health Informatics (3266)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (430)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14625)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4922)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2523)
  • Ophthalmology (723)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4209)
  • Public and Global Health (7501)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1012)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)